Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)
NCT: NCT07754318 · RECRUITING
広告
NCT識別子NCT07754318
ステータスRECRUITING
開始日2026-08-26
SponsorMedtronic Cardiovascular (INDUSTRY)
First posted
Last updated
概要
To evaluate the safety and effectiveness of the Heli-FX EndoAnchor system in AAA subjects who without augmented radial fixation and/or sealing due to an endoleak or migration are at high risk for aneurysm-related complications or who are at high risk of migration or endoleak complications post-procedure, and to support product registration of Heli-FX EndoAnchor system with the National Medical Product Administration (NMPA) in China.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。